Provided herein are novel maytansinoid compounds of general formula I. Also provided herein are conjugates comprising the compounds linked to a binding protein via a linker, and conjugating reagents comprising the compounds attached via a linker to at least one functional group capable of reacting with a binding protein. Also provided herein are pharmaceutical compositions comprising the compounds and conjugates, therapeutic methods and uses involving the compounds and conjugates, for example in cancer therapy, and novel synthetic processes.
本文提供了一般式I的新型马丹西
酮类化合物。本文还提供了将这些化合物通过连接剂连接到结合蛋白上的共轭物,以及将这些化合物通过连接剂连接到至少一个能与结合蛋白发生反应的功能基团的共轭试剂。本文还提供了包含这些化合物和共轭物的药物组合物,涉及这些化合物和共轭物的治疗方法和用途,例如在癌症治疗中,并提供了新的合成过程。